BG107603A - Тартаратни соли на тиазолидиндионово производно - Google Patents

Тартаратни соли на тиазолидиндионово производно Download PDF

Info

Publication number
BG107603A
BG107603A BG107603A BG10760303A BG107603A BG 107603 A BG107603 A BG 107603A BG 107603 A BG107603 A BG 107603A BG 10760303 A BG10760303 A BG 10760303A BG 107603 A BG107603 A BG 107603A
Authority
BG
Bulgaria
Prior art keywords
tartrate
solvate
accordance
compound
pyridyl
Prior art date
Application number
BG107603A
Other languages
Bulgarian (bg)
English (en)
Inventor
Bernadette Choudary
Andrew Craig
Tim HO
Donald MACKENZIE
Deirdre O'keeffe
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG107603A publication Critical patent/BG107603A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
BG107603A 2000-08-04 2003-02-28 Тартаратни соли на тиазолидиндионово производно BG107603A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019223.7A GB0019223D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003506 WO2002012231A1 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative

Publications (1)

Publication Number Publication Date
BG107603A true BG107603A (bg) 2003-09-30

Family

ID=9897025

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107603A BG107603A (bg) 2000-08-04 2003-02-28 Тартаратни соли на тиазолидиндионово производно

Country Status (35)

Country Link
US (1) US20040087629A1 (ja)
EP (1) EP1305310B1 (ja)
JP (1) JP2004505969A (ja)
KR (1) KR100754701B1 (ja)
CN (2) CN101712678A (ja)
AP (1) AP1813A (ja)
AT (1) ATE386739T1 (ja)
AU (1) AU2001276502A1 (ja)
BG (1) BG107603A (ja)
BR (1) BR0112983A (ja)
CA (1) CA2417818A1 (ja)
CY (1) CY1107421T1 (ja)
CZ (1) CZ301281B6 (ja)
DE (1) DE60132897T2 (ja)
DK (1) DK1305310T3 (ja)
DZ (1) DZ3417A1 (ja)
EA (1) EA005295B1 (ja)
EC (1) ECSP034466A (ja)
ES (1) ES2299498T3 (ja)
GB (1) GB0019223D0 (ja)
HK (1) HK1057360A1 (ja)
HR (1) HRP20030067A2 (ja)
HU (1) HUP0300724A3 (ja)
IL (2) IL154274A0 (ja)
MA (1) MA25831A1 (ja)
MX (1) MXPA03001083A (ja)
NO (1) NO324598B1 (ja)
NZ (1) NZ524029A (ja)
PL (1) PL360693A1 (ja)
PT (1) PT1305310E (ja)
SK (1) SK287243B6 (ja)
UA (1) UA76719C2 (ja)
WO (1) WO2002012231A1 (ja)
YU (1) YU14503A (ja)
ZA (1) ZA200300960B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5874454A (en) * 1993-09-15 1999-02-23 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
SG47100A1 (en) * 1994-02-10 1998-03-20 Smithkline Beecham Plc Use of insulin sensitisers for treating renal diseases

Also Published As

Publication number Publication date
GB0019223D0 (en) 2000-09-27
CA2417818A1 (en) 2002-02-14
AU2001276502A1 (en) 2002-02-18
HUP0300724A3 (en) 2005-04-28
MA25831A1 (fr) 2003-07-01
IL154274A0 (en) 2003-09-17
CZ2003315A3 (cs) 2004-02-18
DE60132897D1 (de) 2008-04-03
DZ3417A1 (fr) 2002-02-14
KR20030022354A (ko) 2003-03-15
US20040087629A1 (en) 2004-05-06
NO324598B1 (no) 2007-11-26
CN1455777A (zh) 2003-11-12
BR0112983A (pt) 2003-06-10
HRP20030067A2 (en) 2004-06-30
KR100754701B1 (ko) 2007-09-03
EP1305310B1 (en) 2008-02-20
WO2002012231A1 (en) 2002-02-14
JP2004505969A (ja) 2004-02-26
SK1432003A3 (en) 2004-03-02
MXPA03001083A (es) 2003-05-27
DE60132897T2 (de) 2009-04-09
AP2003002735A0 (en) 2003-03-31
CN101712678A (zh) 2010-05-26
PL360693A1 (en) 2004-09-20
CZ301281B6 (cs) 2009-12-30
IL154274A (en) 2009-02-11
ATE386739T1 (de) 2008-03-15
SK287243B6 (sk) 2010-04-07
AP1813A (en) 2008-01-04
EA200300232A1 (ru) 2003-06-26
NO20030531L (no) 2003-02-03
NZ524029A (en) 2004-07-30
CY1107421T1 (el) 2012-12-19
ES2299498T3 (es) 2008-06-01
DK1305310T3 (da) 2008-06-16
HK1057360A1 (en) 2004-04-02
UA76719C2 (uk) 2006-09-15
NO20030531D0 (no) 2003-02-03
ZA200300960B (en) 2004-04-19
ECSP034466A (es) 2003-06-25
HUP0300724A2 (hu) 2003-11-28
EA005295B1 (ru) 2004-12-30
YU14503A (sh) 2006-01-16
PT1305310E (pt) 2008-05-12
EP1305310A1 (en) 2003-05-02

Similar Documents

Publication Publication Date Title
KR100840846B1 (ko) 5-[4-[2-(ｎ-메틸-ｎ-(2-피리딜)아미노)에톡시]벤질]티아졸리딘-2,4-디온 메실레이트염
KR100755173B1 (ko) 티아졸리딘디온 유도체의 타르트레이트 염
BG107607A (bg) Хидрохлоридна сол на 5-[4-[2-(n-метил-n-(2-пиридил)амино)етокси]бензил]тиазолидин-2,4-дион
KR100769007B1 (ko) 티아졸리딘디온 유도체 및 항당뇨제로서의 그의 용도
BG107604A (bg) Тартаратна сол на тиазолидиндионово производно
BG107603A (bg) Тартаратни соли на тиазолидиндионово производно
BG107605A (bg) Тартаратни соли на тиазолидиндионово производно
KR20030007918A (ko) 당뇨병 치료용 티아졸리딘디온 염
KR100822135B1 (ko) 티아졸리딘디온 유도체 및 항당뇨제로서의 그의 용도
KR20030007919A (ko) 약제로서의5-[4-[2-(ｎ-메틸-ｎ-(2-피리딜)아미노)에톡시]벤질]티아졸리딘-2,4-디온 하이드로요오다이드
KR20040062963A (ko) 5-(4-(2-(ｎ-메틸-ｎ-(2-피리딜)아미노)에톡시)벤질)티아졸리딘-2,4-디온 벤젠술포네이트, 그의 제조 방법, 그의다형체 ⅰ, ⅱ 및 ⅲ, 및 제약상 활성 성분으로서의 그의용도